内皮MAML1相分离异常通过抑制Notch活性导致先天性心脏病
本研究探讨Notch转录共激活因子MAML1在先天性心脏病(CHD)中的作用。通过患者来源Q401K突变敲入小鼠、内皮特异性Maml1敲除小鼠及CRISPR编辑人心脏类器官,发现MAML1变异与室间隔缺损相关,其致病机制为破坏MAML1液-液相分离(LLPS),下调Notch信号并扰乱内皮-间质转化。PKN2磷酸化MAML1 Ser314可负向调控该过程。
要点
- MAML1是CHD候选基因,其罕见错义变异与室间隔缺损相关。
- MAML1 LLPS是内皮细胞Notch转录输出的关键生物物理决定因素。
- PKN2磷酸化MAML1 Ser314可破坏凝聚体并减弱Notch信号。
核心结论
- MAML1为CHD候选基因,其LLPS是内皮细胞Notch转录输出的关键决定因素。
- MAML1凝聚体的静电完整性对心脏形态发生中Notch信号的正确调控至关重要。
- CHD相关电荷改变变异或PKN2介导的异常磷酸化均会损害Notch信号并破坏内皮-间质转化。
研究设计与样本
- 研究采用患者来源Q401K突变敲入小鼠模型和内皮特异性Maml1敲除小鼠模型。
- 辅以CRISPR编辑的人心脏类器官。
- 通过超声心动图和 histological 分析评估心脏表型,并通过生化实验、显微镜分析LLPS及质谱鉴定翻译后修饰和上游激酶。
主要发现
- 在CHD临床队列中鉴定出与室间隔缺损相关的MAML1罕见错义变异。
- 模拟患者来源Q401K变异足以在敲入小鼠和人心脏类器官中重现室间隔缺损相关关键表型。
- 内皮特异性敲除MAML1小鼠和MAML1缺失人心脏类器官通过破坏Notch驱动的内皮-间质转化导致相似的室间隔和瓣膜缺陷。
- MAML1活性依赖LLPS形成核凝聚体,该凝聚体是与NOTCH1胞内域有效相互作用并激活下游转录靶标所必需的。
- 患者来源致病变异(包括Q401K)为内在无序区2内的电荷改变突变,病理性消除LLPS从而下调Notch信号。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Congenital heart disease (CHD), the most common birth defect and a leading cause of infant mortality, is frequently linked to dysregulated Notch signaling. However, the role of the Notch transcriptional coactivator Mastermind-like 1 (MAML1) in CHD pathogenesis and the underlying molecular mechanism remain unclear. METHODS: We investigated the role of MAML1 in CHD by focusing on a patient-derived Q401K mutation with a knock-in mouse model and an endocardium-specific Maml1 knockout mouse model, complemented by CRISPR-edited human heart organoids. Cardiac phenotypes were assessed by echocardiography and histological analysis. The underlying molecular mechanisms were dissected through biochemical assays, microscopy to analyze liquid-liquid phase separation (LLPS), and mass spectrometry to identify posttranslational modifications and the upstream kinase of MAML1. RESULTS: In a clinical cohort of patients with CHD, we identified rare missense variants of MAML1 associated with ventricular septal defects. Modeling a patient-derived variant (Q401K) was sufficient to recapitulate key ventricular septal defect-related phenotypes in both knock-in mice and human heart organoids. To confirm the tissue-specific pathogenicity, we showed that endocardium-specific knockout of MAML1 in mice and MAML1 deletion in human heart organoids caused similar septal and valvular defects by disrupting Notch-driven endocardial-to-mesenchymal transition. Mechanistically, we discovered that MAML1 activity depends on LLPS, which forms nuclear condensates, required for efficient interaction with the NOTCH1 intracellular domain and activation of downstream transcriptional targets. Crucially, patient-derived pathogenic variants, including Q401K, function as charge-altering mutations within the intrinsically disordered region 2, a core region for MAML1 LLPS, pathologically abrogating LLPS to downregulate Notch signaling. Furthermore, we identified a regulatory axis in which PKN2 phosphorylates MAML1 at Ser314, which destabilizes MAML1 condensates and consequently attenuates Notch transcriptional output. CONCLUSIONS: These findings support MAML1 as a candidate gene for CHD and identify MAML1 LLPS as a critical biophysical determinant of Notch transcriptional output in endocardial cells. The electrostatic integrity of MAML1 condensates is essential for proper regulation of Notch signaling during cardiac morphogenesis. Dysregulation of this state, whether through CHD-associated charge-altering variants or aberrant PKN2-mediated phosphorylation, impairs Notch signaling and disrupts endocardial-to-mesenchymal transition, thereby establishing a converged molecular mechanism underlying congenital cardiac malformations.
引用
- Tan Z, Qi Y, Chen Y, et al. Aberrant Phase Separation of Endothelial MAML1 Causes Congenital Heart Disease by Suppressing Notch Activity. Circulation. 2026. PMID: 42246060. doi:10.1161/CIRCULATIONAHA.126.078188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。